Best way to stay updated in the #Oncotwitter 💯💯

Great weekly summaries by the Mr. OncoAlert himself 🤓🤓 Gil Morgan, MD

Happy to see some friends too 🇹🇷🇹🇷 Emre Yekedüz Erman Akkus

Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Marta Perachino Kathrin Heinrich Hidehito HORINOUCHI Dr. Iván R. González…

Really interesting article by Niklas Klümper in EJC 🤓🤓

Post-hoc analyses from the IMvigor211 and IMmotion151 💉💉

A simple and cheap predictor of IO efficacy >Blood sodium levels 🧂🧂

Could be very practical and beneficial for the patients 🤞🤞

A great discussion on the…

Erman Akkus summarizes Adjuvant Aspirin in Breast Cancer
Erman Akkus JAMA JAMA Oncology American Cancer Society Breast Cancer Now Deniz Can Guven Emre Yekedüz Enes Erul MD MRIDUL KHANNA Ann Partridge MD, MPH Olwen Hahn, MD
oncodaily.com/59291.html

#OncoDaily #Oncology #Cancer

🇺🇸US Preventive Services Task Force 'ABD Önleyici Hizmetler Görev Gücü' Meme kanseri tarama önerisi:

🔎40-74 yaş arası kadınlar için iki yılda bir mamografi taraması öneriyor.
⭕️75 yaş üstü ya da yoğun meme dokusuna sahip kadınlar için yararların değerlendirilmesi konusunda…

📢Our new study has been published!
Coskun YAZGAN Emre Yekedüz Yüksel Ürün

📊Prostate Cancer and PARPi: Thromboembolic Risk ❓

🚨Increased risk of thrombosis with PARPi compared to controls: 4.3% vs. 2.2%, OR:1.98, 95% CI: 1.06-3.70, P=0.030

⁉️Should be considered when…

📢📗
Merkel-cell carcinoma guideline of ESMO - Eur. Oncology and EURACAN

✅Management of locaregional and advanced/metastatic disease

👉doi.org/10.1016/j.esmo…

ESMO Open EADV Türk Dermatoloji Derneği The Skin Cancer Foundation 👒 Enes Erul MD Beliz Bahar Karaoğlan
OncoAlert OncoDaily
#cancer #oncology #skin #MedX

🎉 Huge congratulations to the team for hard work and dedication!
Brilliant job Coskun YAZGAN Erman Akkus Emre Yekedüz !
OncoAlert Advanced Prostate Cancer Consensus Conference Prostate Cancer Foundation Ankara Üniversitesi Ankara Üniversitesi Tıp Fakültesi
sciencedirect.com/science/articl…

📢Unlocking the Mystery of HPV in Male Urogenital Cancer: Dive into our comprehensive review revealing HPV's prevalence and oncogenic mechanisms #HPV #Cancer #Oncology #Urooncology Yüksel Ürün MDPI OncoAlert Emre Yekedüz
doi.org/10.3390/v16050…

Just out🎉🎉🎉 Our paper assessing the risk of thromboembolic events in patients with prostate cancer treated with PARPi just published!
doi.org/10.1016/j.crit…
OncoAlert Yüksel Ürün Emre Yekedüz Erman Akkus

🩸New ASH guidelines on VTE in cancer patients: Strongly recommend LMWH for initial VTE treatment. Thromboprophylaxis advised for high-risk cases but not for low-risk chemotherapy patients.
#VTE #CancerCare #ASH
Alok Khorana, MD Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 Cihan Ay ASH Blood Advances…

A new star Tom Powles now rises in prostate cancer at Advanced Prostate Cancer Consensus Conference
Uromigos silke gillessen OncoAlert Brian Rini, MD Toni Choueiri, MD

📚Annual Turkish Medical Oncology Congress has begun in Cyprus!
#TTOK2024 TTOD

Some points from palliative and supportive care session:

✅Ondansetron max 8mg in >75y, due to cardiac effects
✅Single-dose iv fosaprepitant (150 mg) is noninferior to standard 3-day…

⁉️Perioperative management of locally advanced adenocarcinoma of the oesophagus and EGJ: CRT or ChT?

✅In Neo-Aegis, CRT provided better pCR and RO, but OS was similar. However, FLOT was included laterly in this study (only n=27(15%) had FLOT).

❗️⏱️ Results of ESOPEC trial…

Love this iconic cartoon of the Newyorker
Reflecting on health paradoxes in #oncology

The tobacco-free generation proposal | Tobacco Control🚭
A visionary step towards a smoke-free future! Supporting legislation to stop tobacco sales to future generations is key to protecting health and ensuring fairness. #TobaccoFreeGen #HealthForAll 💪 tobaccocontrol.bmj.com/content/22/sup…

👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community.
Access with your ESMO account: 🔗ow.ly/QbL750Rj8oz

Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis

🚨Early-onset colorectal cancer (EOCRC, 20-49 y) incidence is increasing worldwide: Norway data
ESMO Open

➡️1993 and 2022
❗️Incidence of EOCRC increased by 66% (average annual percentage change, AAPC 1.3)
❗️Mainly left-sided colon and rectal cancers
✔️Age group 50-74 years:…

“I recommend we have a robust social media presence to educate...You don’t need thousands of followers...It’s not just 1 person making change, it’s all of us…You’ve already taken 1 step towards making change by being here.”
Thx Dr. Glaucomflecken for coming to #ASCOAdvocacySummit !

🦷💊 CDK 4/6 inh. may cause osteonecrosis of the jaw (MRONJ) ⁉️

➡️Recent reports have hinted at a connection between palbociclib and MRONJ, particularly in females. This study used 'FDA adverse events reporting system' to explore this association.

➡️Signals of MRONJ were found…

Excellent study at JAMA Oncology about symptom management for life extension - Enes Erul MD
ESMO - Eur. Oncology ESOncology

#ASCO #Cancer #Cancer Care #Cancer Research #ESMO #OncoDaily #Oncology

oncodaily.com/48884.html